Effect of Euryale Ferox on the Expression of GLUT1 and TGF-β_1 in the Renal Tissues of Diabetic Nephropathy Rats
Dong Wenhu
Abstract
Dong Wenhu
Abstract
Objective: To investigate the effect of euryale ferox on the expression of GLUT1 and TGFβ1 in renal tissues of diabetic nephropathy rats. Methods: 60 SD male rats were randomly divided into 6 groups : the normal control group( group N),diabetic nephropathic model group( group DN),low- dose Euryale ferox group( EL,1. 5 g·kg- 1·d- 1),medium- dose Euryale ferox group( EM,3. 0g / kg / d),high- dose Euryale ferox group( EH,6. 0 g·kg- 1·d- 1) and losartan potassium group( LP,30 mg·kg- 1·d- 1). Rats were treated respectively by intragastric administration for 12 weeks. Meanwhile rats of group N and group DN received the same volume distilled water by gavage. Blood serum creatinine,blood urea nitrogen and 24 h urinary protein were measured after the research. The renal pathological changes were observed by histochemistry staining and electron microscope. The expression of GLUT1 and TGF- β1was detected by immunohistochemistry and western blot. Results: Compared with group N,the glomerular became hypertrophic and the mesangial matrix increased in group DN. BUN,Scr,24 h urinary protein also increased significantly( P 0. 05). Meanwhile the expression of GLUT1 and TGF- β1in renal tissues increased significantly( P 0. 05). Compared with group DN,the pathology changes were relieved,BUN,Scr,24 h urinary protein as well as the expression of GLUT1 and TGF- β1decreased in group EM and group EH( P 0. 05). In addition,there was no significant difference in effect of reducing erinary protein in group EM,EH and LP. Conclusion: Euryale ferox may delay the injury in diabetic nephropathy by down- regulating the expression of GLUT1 and TGF- β1.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of euryale ferox on the expression of GLUT1 and TGFβ1 in renal tissues of diabetic nephropathy rats. Methods: 60 SD male rats were randomly divided into 6 groups : the normal control group( group N),diabetic nephropathic model group( group DN),low- dose Euryale ferox group( EL,1. 5 g·kg- 1·d- 1),medium- dose Euryale ferox group( EM,3. 0g / kg / d),high- dose Euryale ferox group( EH,6. 0 g·kg- 1·d- 1) and losartan potassium group( LP,30 mg·kg- 1·d- 1). Rats were treated respectively by intragastric administration for 12 weeks. Meanwhile rats of group N and group DN received the same volume distilled water by gavage. Blood serum creatinine,blood urea nitrogen and 24 h urinary protein were measured after the research. The renal pathological changes were observed by histochemistry staining and electron microscope. The expression of GLUT1 and TGF- β1was detected by immunohistochemistry and western blot. Results: Compared with group N,the glomerular became hypertrophic and the mesangial matrix increased in group DN. BUN,Scr,24 h urinary protein also increased significantly( P 0. 05). Meanwhile the expression of GLUT1 and TGF- β1in renal tissues increased significantly( P 0. 05). Compared with group DN,the pathology changes were relieved,BUN,Scr,24 h urinary protein as well as the expression of GLUT1 and TGF- β1decreased in group EM and group EH( P 0. 05). In addition,there was no significant difference in effect of reducing erinary protein in group EM,EH and LP. Conclusion: Euryale ferox may delay the injury in diabetic nephropathy by down- regulating the expression of GLUT1 and TGF- β1.
Key concepts: Endocrinology, Diabetic nephropathy, Internal medicine, Creatinine, Blood urea nitrogen, Chemistry, Western blot, Renal function